Neumora Therapeutics, Inc. (NMRA) Reports In-Line Q1 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/15/2026
- Nasdaq ends sharply lower as hot inflation data stirs rate-hike worries
- Oil prices gain on attacks in Saudi Arabia, Iran's new tactics to target tankers
- U.S. consumer prices rise by 3.7% year-on-year in September
- Bank of America stock falls on earnings miss
- Netflix cuts 1,000 jobs as streaming giant seeks to boost engagement
Tweet
Share
E-mailGet Alerts NMRA Hot Sheet
Join SI Premium – FREE
Neumora Therapeutics, Inc. (NASDAQ: NMRA) reported Q1 EPS of ($0.30), in-line with the analyst estimate of ($0.30).
For earnings history and earnings-related data on Neumora Therapeutics, Inc. (NMRA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Surge Components, Inc. (SPRS) Tops Q3 EPS by 4c
- Winmark Corp (WINA) Misses Q3 EPS by 2c
- Fed's Daly: rate hikes likely, but not urgent - Reuters
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
